An open-label trial of the immunogenicity and safety of Prevenar (pneumococcal 7-valent conjugate vaccine [diphteria CRM197 protein conjugate] [Pneumococcal 7-valent CRM197 vaccine conjugate] in healthy infants at 2,4 and 6 months of age

Trial Profile

An open-label trial of the immunogenicity and safety of Prevenar (pneumococcal 7-valent conjugate vaccine [diphteria CRM197 protein conjugate] [Pneumococcal 7-valent CRM197 vaccine conjugate] in healthy infants at 2,4 and 6 months of age

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 May 2007

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Sponsors Wyeth
  • Most Recent Events

    • 25 May 2007 Status changed from in progress to completed.
    • 31 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top